Skip to main content
. 2021 Sep 20;8(5):ENEURO.0143-21.2021. doi: 10.1523/ENEURO.0143-21.2021

Figure 8.

Figure 8.

Thermal hyperalgesia following repeated neonatal morphine exposure. A, In examining normalized thermal nociceptive sensitivity on the 52.5°C hot plate, RM ANOVA (treatment and sex as factors; postnatal day as the RM) revealed a main effect of treatment (F(1,72) = 65.01, *p < 0.001) but no effect of sex (F(1,72) = 0.52; p = 0.47) or postnatal day (F(1,72) = 0.04; p = 0.85), and no interactions (all p values ≥ 0.24). Morphine-treated pups displayed a nociceptive response of 8.91 ± 1.11 s (mean ± SEM) sooner (p < 0.001) than saline-treated pups on average, supporting the presence of hyperalgesia. B, In examining normalized thermal nociceptive sensitivity in the 48.5°C tail withdrawal assay, RM ANOVA (treatment and sex as factors, postnatal day as a repeated measure) indicated a main effect of treatment (F(1,70) = 60.98, p < 0.001), postnatal day (F(1,70) = 4.96, p = 0.029), and a treatment × sex interaction (F(1,70) = 4.83, p = 0.03). However, there were no interactions with day (p values > 0.19), and, thus, tail withdrawal latencies were averaged across P7 and P14 to more clearly and specifically illustrate the treatment × sex interaction. Post hoc analysis revealed lower latencies in both morphine-treated males and females relative to all saline groups (Tukey’s test: SAL males vs MOR males, p = 0.002; SAL males vs MOR females, p < 0.001; SAL females vs MOR females, p < 0.001; SAL females vs MOR males, p < 0.001). While there was no difference in latencies between saline-treated males and females (p = 0.99), there was a nonsignificant lower latency in morphine-treated females compared with morphine-treated males (p = 0.072), hinting at greater hyperalgesia. Data are presented as the mean ± SEM of raw (non-normalized) data, averaged across P7 and P14.